JLE

Journal de Pharmacie Clinique

MENU

Pharmaceutical analysis of prescriptions in care units using the French Society of Clinical Pharmacy’s intervention sheet. Volume 26, issue 1, Janvier-Février-Mars 2007

Figures

See all figures

Author
Service pharmacie, BP 246, 88100 Saint-Die

The aim of this study carried out both in surgery and medicine departments is dual: 1) to compare the contents of each pharmaceutical intervention, and its acceptance in surgery and medicine departments (respectively 69 and 100 beds); 2) to report on positive returns, but also limits, of the pharmaceutical intervention sheet, recently approved by the French Society of Clinical Pharmacy, used in this study. From January 1 st, 2006 through April 30, 2006, 820 prescriptions were assessed, leading to 98 pharmaceutical interventions (12%), especially in surgery departments (18.5% versus 9.4% for medicine units p<0.001). The main identified problems concerned treatments which should not have been prescribed (47.6%) in surgery departments; in parallel, a lack of compliance (26.8%), excessive dosages (21.4%), and drug interactions (19.6%) in medicine departments were observed. The most concerned drugs in surgery units were the blood and hematopoietic system drugs (54.8%); in medicine departments, they were cardiovascular system (41.1%) and nervous system drugs (25%). Pharmaceutical interventions’ acceptance was better in medicine units (89.3% versus 54.8% p<0.001). In both departments, it mainly concerned a drug interruption (44.9%). Except treatment interruptions suggestions in surgery, the pharmaceutical interventions were well accepted. Although the French Society of Clinical Pharmacy’s intervention sheet seems adapted, we suggest a few improvements.